• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Acentra Health Earns Fourth Consecutive Recognition on the Washington Business Journal's Annual 'Largest Private Companies' List

    6/30/25 9:34:00 AM ET
    $CG
    Investment Managers
    Finance
    Get the next $CG alert in real time by email

    MCLEAN, Va., June 30, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, has earned the No. 43 spot on the Washington Business Journal's 2025 list of the largest private companies by revenue across the Washington, D.C., region.

    Over the last four years, Acentra Health has climbed 23 spots on WBJ's Largest Private Companies List. The upward momentum signals the company's sustained revenue growth and increased market share, fueled by strategic investments in its solutions and its workforce.

    "This recognition reflects Acentra Health's unwavering commitment to innovation and the impact of our deep expertise across government, healthcare, and technology," said Todd Stottlemyer, CEO, Acentra Health. "As a vital partner for health solutions in the public and commercial sectors, we bring together advanced technology, clinical insight, and policy fluency to deliver solutions that increase access to quality healthcare and improve outcomes."

    Acentra Health's continued growth reflects the strength of its dedicated, highly skilled team, professionals with decades of experience across diverse healthcare settings. The company's mission-driven focus shapes its approach to client service and technology enablement, accelerating its ongoing momentum.

    "These rankings reflect the growing trust placed in us by state, federal, and commercial clients to solve complex healthcare challenges," said Meghan Harris, President & Chief Operations Officer, Acentra Health. "We take pride in listening to our clients and helping them improve health outcomes for priority populations, whether we are delivering smart technology solutions, deploying large system implementations, or using advanced analytics to inform better care decisions."

    Today, Acentra Health serves clients in all 50 states, partnering with 47 state Medicaid agencies and 25 federal agencies to improve access to care for more than 140 million beneficiaries. With 3,400 employees across the U.S. and India, the company continues to scale its impact through a combination of strategic investments in technology and workforce development, driving efficiency and cost savings.

    This achievement continues a pattern of consistent growth and recognition for Acentra Health. In 2024, the company was honored with the Association for Corporate Growth National Capital Chapter's Corporate Growth Award and earned a place on the Washington Business Journal's Fastest Growing Companies list.

    To view the full list of the Washington Business Journal's Largest Private Companies, click here.

    About Acentra Health

    Acentra Health combines public sector knowledge, clinical expertise, and technological ingenuity to modernize the healthcare experience for state, federal, and commercial partners, and their priority populations. From designing and developing advanced claims, encounter, and provider solutions that drive efficiency and cost savings to delivering clinically focused service models for care management, clinical assessments, and quality oversight, Acentra Health is accelerating better health outcomes. Acentra Health is backed by Carlyle (NASDAQ:CG), a global investment firm. Learn more at acentra.com.

    Media Contact:

    Janice Moore

    Vice President, Corporate Communications

    703-214-3552



    Primary Logo

    Get the next $CG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CG

    DatePrice TargetRatingAnalyst
    5/14/2025$56.00Hold → Buy
    TD Cowen
    3/19/2025Outperform → Perform
    Oppenheimer
    1/3/2025$60.00Peer Perform → Outperform
    Wolfe Research
    9/12/2024$42.00Equal Weight
    Wells Fargo
    8/27/2024$55.00Buy
    Redburn Atlantic
    8/6/2024$46.00 → $44.00Overweight → Neutral
    JP Morgan
    1/19/2024$40.00 → $41.00Buy → Neutral
    Citigroup
    1/4/2024$42.00Market Perform
    TD Cowen
    More analyst ratings

    $CG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Carlyle Group Inc. sold $100,225,698 worth of shares (3,671,271 units at $27.30) (SEC Form 4)

      4 - Carlyle Group Inc. (0001527166) (Reporting)

      6/2/25 4:30:39 PM ET
      $CG
      Investment Managers
      Finance
    • General Counsel Ferguson Jeffrey W. was granted 1,368 shares, increasing direct ownership by 0.12% to 1,097,293 units (SEC Form 4)

      4 - Carlyle Group Inc. (0001527166) (Issuer)

      5/29/25 5:09:59 PM ET
      $CG
      Investment Managers
      Finance
    • Chief Executive Officer Schwartz Harvey M was granted 31,709 shares, increasing direct ownership by 0.51% to 6,188,889 units (SEC Form 4)

      4 - Carlyle Group Inc. (0001527166) (Issuer)

      5/29/25 5:09:50 PM ET
      $CG
      Investment Managers
      Finance

    $CG
    SEC Filings

    See more
    • The Carlyle Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Submission of Matters to a Vote of Security Holders

      8-K - Carlyle Group Inc. (0001527166) (Filer)

      5/30/25 5:19:46 PM ET
      $CG
      Investment Managers
      Finance
    • Amendment: SEC Form SCHEDULE 13G/A filed by The Carlyle Group Inc.

      SCHEDULE 13G/A - Carlyle Group Inc. (0001527166) (Subject)

      5/13/25 11:44:13 AM ET
      $CG
      Investment Managers
      Finance
    • SEC Form 13F-HR filed by The Carlyle Group Inc.

      13F-HR - Carlyle Group Inc. (0001527166) (Filer)

      5/9/25 4:37:58 PM ET
      $CG
      Investment Managers
      Finance

    $CG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Acentra Health Earns Fourth Consecutive Recognition on the Washington Business Journal's Annual 'Largest Private Companies' List

      MCLEAN, Va., June 30, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, has earned the No. 43 spot on the Washington Business Journal's 2025 list of the largest private companies by revenue across the Washington, D.C., region. Over the last four years, Acentra Health has climbed 23 spots on WBJ's Largest Private Companies List. The upward momentum signals the company's sustained revenue growth and increased market share, fueled by strategic investments in its solutions and its workforce. "This recognition reflects

      6/30/25 9:34:00 AM ET
      $CG
      Investment Managers
      Finance
    • Diversified Energy and Carlyle Enter Strategic Partnership to Invest in Up to $2 Billion of PDP Energy Assets

      BIRMINGHAM, Ala. and NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Diversified Energy Company PLC ((LSE: DEC, NYSE:DEC) ("Diversified," or "DEC"), a leading publicly traded natural gas and liquids production company, and global investment firm Carlyle (NASDAQ:CG) have today announced a strategic partnership to invest in up to $2 billion in existing proved developed producing (PDP) natural gas and oil assets across the United States. This exclusive partnership will combine Carlyle's deep credit and structuring expertise, led by Carlyle's asset-backed finance (ABF) team, with Diversified's market-leading operating capabilities and differentiated business model of acquiring and optimizing port

      6/23/25 4:31:00 PM ET
      $CG
      $DEC
      Investment Managers
      Finance
    • Trucordia to Receive $1.3 Billion Strategic Investment from Carlyle

      Transaction positions company for accelerated growth through improved capital structure and simplified governance LINDON, Utah and NEW YORK, June 4, 2025 /PRNewswire/ -- Trucordia today announced it will receive a $1.3 billion strategic investment from global investment firm Carlyle's Global Credit platform. The transaction will reduce Trucordia's leverage and simplify its governance structure by repurchasing units from existing minority investors. The transaction, which is expected to close this month and values Trucordia at $5.7 billion, provides the company with long-term

      6/4/25 7:00:00 AM ET
      $CG
      Investment Managers
      Finance

    $CG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Carlyle Group upgraded by TD Cowen with a new price target

      TD Cowen upgraded Carlyle Group from Hold to Buy and set a new price target of $56.00

      5/14/25 8:48:54 AM ET
      $CG
      Investment Managers
      Finance
    • Carlyle Group downgraded by Oppenheimer

      Oppenheimer downgraded Carlyle Group from Outperform to Perform

      3/19/25 8:14:15 AM ET
      $CG
      Investment Managers
      Finance
    • Carlyle Group upgraded by Wolfe Research with a new price target

      Wolfe Research upgraded Carlyle Group from Peer Perform to Outperform and set a new price target of $60.00

      1/3/25 7:19:04 AM ET
      $CG
      Investment Managers
      Finance

    $CG
    Leadership Updates

    Live Leadership Updates

    See more
    • SoftBank Group to Acquire Ampere Computing

      SoftBank Group Corp. (TSE: 9984, "SoftBank Group") today announced that it will acquire Ampere® Computing, a leading independent silicon design company, in an all-cash transaction valued at $6.5 billion. Under the terms of the agreement, Ampere will operate as a wholly owned subsidiary of SoftBank Group and retain its name. As part of the transaction, Ampere's lead investors – Carlyle (NASDAQ:CG) and Oracle Corp. (NYSE:ORCL) – are selling their respective positions in Ampere. As SoftBank Group broadens its AI infrastructure investments in ventures such as Cristal intelligence and Stargate, the acquisition will help enhance SoftBank Group's capabilities in key areas and accelerate its growt

      3/19/25 7:30:00 PM ET
      $CG
      $ORCL
      Investment Managers
      Finance
      Computer Software: Prepackaged Software
      Technology
    • Acentra Health Welcomes Distinguished Public Sector Health Leaders Calder Lynch and Jami Snyder to its Healthcare Advisory Board; Appoints Julie Boughn as New Chair

      MCLEAN, Va., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, today announced the appointment of Calder Lynch and Jami Snyder to its healthcare advisory board. With decades of experience leading state and federal government healthcare programs, the subject matter experts will advise the company and its clients on healthcare policies and trends as well as strategies to improve health outcomes at a lower cost. "We are excited to welcome Calder Lynch and Jami Snyder to Acentra Health's Healthcare Advisory Boar

      2/4/25 9:58:04 AM ET
      $CG
      Investment Managers
      Finance
    • Acentra Health Appoints Ezmeralda Sager as Chief Transformation Officer

      MCLEAN, Va., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced it has appointed Ezmeralda Sager as Executive Vice President and Chief Transformation Officer (CTO), effective January 6, 2025. In this role, Sager will spearhead enterprise-wide change initiatives to help Acentra Health build upon its strong track record of innovation and execution for its clients. She will provide strategic guidance on process improvements to optimize the development and delivery of the company's products, solutions

      1/23/25 9:42:00 AM ET
      $CG
      Investment Managers
      Finance

    $CG
    Financials

    Live finance-specific insights

    See more
    • Carlyle Secured Lending, Inc. Announces Financial Results For First Quarter Ended March 31, 2025, Declares Second Quarter 2025 Dividend of $0.40 Per Common Share

      NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ:CGBD) today announced its financial results for its first quarter ended March 31, 2025. Justin Plouffe, CGBD's Chief Executive Officer, said, "Following successful completion of the merger with CSL III at the end of March, CGBD remains focused on driving stable income, consistent credit performance, and disciplined execution of our strategy. Complementing our conservative investing approach, we continue to optimize the capital structure of CGBD, increasing total commitments on our credit facility and exchanging the pre

      5/6/25 4:05:00 PM ET
      $CG
      $CGBD
      Investment Managers
      Finance
      Finance: Consumer Services
    • Carlyle Credit Income Fund Schedules Second Quarter Financial Results and Investor Conference Call

      NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund ("we," "us," "our," "CCIF" or the "Fund") (NYSE:CCIF) announced today that it will release financial results after market close on Tuesday, May 20, 2025, for its second quarter of 2025. CCIF will host a conference call at 10:00 a.m. EST on Wednesday, May 21, 2025, to discuss the results. The conference call will be available via public webcast via a link on Carlyle Credit Income Fund's website at www.carlylecreditincomefund.com and will also be available on the website soon after the call's completion. About Carlyle Credit Income Fund Carlyle Credit Income Fund (NYSE:CCIF) is an externally managed closed-end f

      4/16/25 4:46:22 PM ET
      $CCIF
      $CG
      Finance/Investors Services
      Finance
      Investment Managers
    • Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its Financial Results for the First Quarter Ended March 31, 2025

      NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. ("Carlyle Secured Lending") (NASDAQ:CGBD) will host a conference call at 11:00 a.m. EST on Wednesday, May 7, 2025 to announce its financial results for the first quarter ended March 31, 2025. The Company will report its quarterly financial results on Tuesday, May 6, 2025. The conference call will be available via public webcast via a link on Carlyle Secured Lending's website at carlylesecuredlending.com and will also be available on the website soon after the call's completion. About Carlyle Secured Lending, Inc. Carlyle Secured Lending, Inc. is a publicly traded (NASDAQ:CGBD) business development company (

      4/15/25 4:25:17 PM ET
      $CG
      $CGBD
      Investment Managers
      Finance
      Finance: Consumer Services

    $CG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

      SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)

      11/15/24 5:22:29 PM ET
      $CG
      Investment Managers
      Finance
    • Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

      SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

      10/21/24 4:31:27 PM ET
      $CG
      Investment Managers
      Finance
    • Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

      SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

      10/15/24 4:31:27 PM ET
      $CG
      Investment Managers
      Finance